The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment.
about
Intestinal microbiota in functional bowel disorders: a Rome foundation reportProbiotic effects on intestinal fermentation patterns in patients with irritable bowel syndromeAntibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of ResistancesGut microbiota and gastrointestinal health: current concepts and future directionsGut microbiota as potential orchestrators of irritable bowel syndromeIrritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders.Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in PakistanDeviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBDThe gut microbiota and irritable bowel syndrome: friend or foe?Diagnosis of small intestinal bacterial overgrowth: the challenges persist!The comparison of treatments with and without azithromycin in irritable bowel syndrome with diarrhea-predominant in gastrointestinal Clinic of Al-Zahra Hospital, Isfahan, Iran.Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failureTaste receptors of the gut: emerging roles in health and disease.Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.Irritable Bowel Syndrome and the Small Intestinal Microflora. What Do We Know?Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.The role of small intestinal bacterial overgrowth in the pathophysiology of irritable bowel syndrome.Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea.Do Patients with Functional Gastrointestinal Disorders have an Altered Gut Flora?Microflora modulation of motility.A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile.Lactulose hydrogen breath test and functional symptoms in pediatric patients.Measurement of oro-caecal transit time by magnetic resonance imaging.
P2860
Q24631357-93CD0B6E-5673-4B43-8EE1-3720392F9922Q24655815-0A0BC34E-BF5C-4D5B-B9EC-0B0D6603BF79Q26770392-AFA2EDCC-EE48-42A7-8BF5-E6937C13AD87Q26865880-F864FFC9-F783-4E39-A9A5-114BA828227AQ28085584-57A26132-BD30-49EE-810C-82C54C1E42CAQ34410012-C3591814-86BC-41B5-8951-0149756CC704Q34977681-DD7263E8-4807-4650-864B-C2E96B237FA8Q35564307-2DD47E66-0EAA-4838-A8D0-7B42005EEC48Q35631365-470143F0-3214-463D-AE62-426250A24A4BQ35942511-F7773D84-4829-49BD-BDE6-1881148A53EEQ37390656-332F0D53-638E-4818-8E9C-4C632CBE9860Q37504612-2508C12E-6B5F-4020-8282-0FBD2579B6C5Q37831805-1421D7D4-14A7-45A4-ABD3-6123E057661EQ38153130-F23189BA-6B0B-4DBB-813E-54E15DA030C8Q38275041-DEB3EDD0-A287-4624-9EC4-0044A7DDBF03Q38528094-92E68CCF-2CC2-45BD-949F-C542D4309C2DQ38865456-C8E2CBFE-D681-4E41-BE71-44D9ED8E12F1Q40853927-CA4DA713-CA44-42C9-8405-7DCE0C04660DQ40854157-543FCB49-2E24-4EC4-A432-5CB528A276DFQ41172953-F0850A19-E313-4AAA-A53B-4883F20FD4AAQ42732314-2711A6AA-A06D-4A82-AFDE-3420A3CA19F2Q44590290-0636A2A9-EF9C-44B9-85EC-B65DB41CBC50Q46319853-2E688586-A5D0-4784-AA1F-363ECB3CF66CQ51432735-F10859C4-5C53-4871-A4D4-AF8AFC0AA014Q51667996-AFE4C197-9558-4F57-80B1-FAAD2BA1BA8C
P2860
The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The small intestinal bacterial ...... s: implications for treatment.
@en
The small intestinal bacterial ...... s: implications for treatment.
@nl
type
label
The small intestinal bacterial ...... s: implications for treatment.
@en
The small intestinal bacterial ...... s: implications for treatment.
@nl
prefLabel
The small intestinal bacterial ...... s: implications for treatment.
@en
The small intestinal bacterial ...... s: implications for treatment.
@nl
P356
P1433
P1476
The small intestinal bacterial ...... s: implications for treatment.
@en
P2093
P304
P356
10.1136/GUT.2007.133629
P407
P577
2008-02-04T00:00:00Z